Cargando…
Specific pathologist responses for Standard for Exchange of Nonclinical Data (SEND)
The Standard for Exchange of Nonclinical Data (SEND), introduced by the US Food and Drug Administration (FDA), is a scheme for the computerization, electronic application, and screening of preclinical data. Since its establishment, related organizations have been working together to implement SEND....
Autores principales: | Watanabe, Atsushi, Kusuoka, Osamu, Sato, Norihiro, Nakazono, Osamu, Wasko, Michael, Potenta, Daniel, Nakae, Dai, Hatakeyama, Hirofumi, Iwata, Hijiri, Naota, Misaki, Anzai, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Toxicologic Pathology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545672/ https://www.ncbi.nlm.nih.gov/pubmed/28798527 http://dx.doi.org/10.1293/tox.2017-0019 |
Ejemplares similares
-
Responses to the Standard for Exchange of Nonclinical Data (SEND) in non-US countries
por: Anzai, Takayuki, et al.
Publicado: (2015) -
Establishment of the Global SEND Alliance (G-SEND) in Japan and efficient
creation of electronic SEND datasets between CROs
por: Anzai, Takayuki, et al.
Publicado: (2019) -
Contribution of toxicologic pathologists for the safety of human health in
biomedical research—past, present, and future of the JSTP
por: Enomoto, Makoto, et al.
Publicado: (2021) -
Impact of altered dietary calcium–phosphorus ratio caused by high-phosphorus diets in a rat chronic kidney disease (CKD) model created by partial ligation of the renal arteries
por: Watanabe, Atsushi, et al.
Publicado: (2020) -
Considerations of the Japanese Research Working Group for the ICH S6 & Related Issues Regarding Nonclinical Safety Assessments of Oligonucleotide Therapeutics: Comparison with Those of Biopharmaceuticals
por: Hirabayashi, Yoko, et al.
Publicado: (2021)